These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20581796)

  • 1. Financial incentives to improve adherence to medication in five patients with schizophrenia in the Netherlands.
    Staring AB; Mulder CL; Priebe S
    Psychopharmacol Bull; 2010; 43(1):5-10. PubMed ID: 20581796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of financial incentives on patients' motivation for treatment: results of "Money for Medication," a randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
    BMC Psychiatry; 2018 May; 18(1):144. PubMed ID: 29793451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients' and clinicians' perspectives after a 12-month randomized controlled trial.
    Noordraven EL; Schermer MHN; Blanken P; Mulder CL; Wierdsma AI
    BMC Psychiatry; 2017 Aug; 17(1):313. PubMed ID: 28851345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).
    Priebe S; Burton A; Ashby D; Ashcroft R; Burns T; David A; Eldridge S; Firn M; Knapp M; McCabe R
    BMC Psychiatry; 2009 Sep; 9():61. PubMed ID: 19785727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
    Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders.
    Noordraven EL; Audier CH; Staring AB; Wierdsma AI; Blanken P; van der Hoorn BE; Roijen LH; Mulder CL
    BMC Psychiatry; 2014 Dec; 14():343. PubMed ID: 25438877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial.
    Priebe S; Yeeles K; Bremner S; Lauber C; Eldridge S; Ashby D; David AS; O'Connell N; Forrest A; Burns T
    BMJ; 2013 Oct; 347():f5847. PubMed ID: 24100934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of financial incentives on adherence to antipsychotic depot medication: does it change over time?
    Pavlickova H; Bremner SA; Priebe S
    J Clin Psychiatry; 2015 Aug; 76(8):e1029-34. PubMed ID: 26335089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is our clinical practice of antipsychotic relapse prevention in schizophrenia really evidence-based].
    Schanda H; Stompe T
    Neuropsychiatr; 2010; 24(1):14-26. PubMed ID: 20146916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?
    Moran K; Priebe S
    Qual Life Res; 2016 Aug; 25(8):1897-902. PubMed ID: 26850023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
    BMC Res Notes; 2018 Sep; 11(1):655. PubMed ID: 30201054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia.
    Rosenheck RA; Krystal JH; Lew R; Barnett PG; Thwin SS; Fiore L; Valley D; Huang GD; Neal C; Vertrees JE; Liang MH;
    Clin Trials; 2011 Apr; 8(2):196-204. PubMed ID: 21270143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial.
    Henderson C; Knapp M; Yeeles K; Bremner S; Eldridge S; David AS; O'Connell N; Burns T; Priebe S
    PLoS One; 2015; 10(10):e0138816. PubMed ID: 26448540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment adherence in schizophrenia and schizoaffective disorder.
    Goff DC; Hill M; Freudenreich O
    J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving treatment adherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2011 Sep; 72(9):e28. PubMed ID: 21951990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study.
    Brnabic AJ; Kelin K; Ascher-Svanum H; Montgomery W; Kadziola Z; Karagianis J
    Int J Clin Pract; 2011 Sep; 65(9):945-53. PubMed ID: 21849009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.